[HTML] nih.gov

[HTML][HTML] ERO1α promotes hypoxic tumor progression and is associated with poor prognosis in pancreatic cancer

N Gupta, JE Park, W Tse, JK Low, OL Kon… - Oncotarget, 2019 - ncbi.nlm.nih.gov
Pancreatic cancer is a leading cause of mortality worldwide due to the difficulty of detecting
early-stage disease and our poor understanding of the mediators that drive progression of …
被引用次数：29 相关文章

[引用][C] ERO1α promotes hypoxic tumor progression and is associated with poor prognosis in pancreatic cancer

N Gupta, JE Park, W Tse, JK Low, OL Kon, N McCarthy… - Oncotarget, 2019 - cir.nii.ac.jp
ERO1α promotes hypoxic tumor progression and is associated with poor prognosis in
pancreatic cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
[PDF] scienceopen.com

[PDF][PDF] ERO1α promotes hypoxic tumor progression and is associated with poor prognosis in pancreatic cancer

N Gupta, JE Park, W Tse, JK Low, OL Kon, N McCarthy… - scienceopen.com
Pancreatic cancer is a leading cause of mortality worldwide due to the difficulty of detecting
early-stage disease and our poor understanding of the mediators that drive progression of …
[PDF] archive.org

[PDF][PDF] ERO1α promotes hypoxic tumour progression and is associated with poor prognosis in pancreatic cancer

N Gupta, JE Park, W Tse, JK Low, OL Kon, N McCarthy… - scholar.archive.org
ERO1α promotes hypoxic tumour progression and is associated with poor prognosis in
pancreatic cancer Nikhil Gupta1, Jung Eun Pa Page 1 1 ERO1α promotes hypoxic tumour …
[PDF] semanticscholar.org

[PDF][PDF] ERO1α promotes hypoxic tumor progression and is associated with poor prognosis in pancreatic cancer

N Gupta, JE Park, W Tse, JK Low, OL Kon, N McCarthy… - pdfs.semanticscholar.org
Pancreatic cancer is a leading cause of mortality worldwide due to the difficulty of detecting
early-stage disease and our poor understanding of the mediators that drive progression of …

ERO1α promotes hypoxic tumour progression and is associated with poor prognosis in pancreatic cancer

N Gupta, JE Park, W Tse, JK Low, OL Kon, N McCarthy… - bioRxiv, 2019 - biorxiv.org
Pancreatic cancer is a leading cause of mortality worldwide due to difficulty detecting early-
stage disease and our poor understanding of the mediators that drive the progression of …

ERO1α promotes hypoxic tumor progression and is associated with poor prognosis in pancreatic cancer.

N Gupta, JE Park, W Tse, JK Low, OL Kon… - Oncotarget, 2019 - qmro.qmul.ac.uk
Pancreatic cancer is a leading cause of mortality worldwide due to the difficulty of detecting
early-stage disease and our poor understanding of the mediators that drive progression of …

ERO1α promotes hypoxic tumor progression and is associated with poor prognosis in pancreatic cancer

N Gupta, JE Park, W Tse, JK Low, OL Kon, N McCarthy… - Oncotarget, 2019 - dr.ntu.edu.sg
Pancreatic cancer is a leading cause of mortality worldwide due to the difficulty of detecting
early-stage disease and our poor understanding of the mediators that drive progression of …
[HTML] oncotarget.com

[HTML][HTML] ERO1α promotes hypoxic tumor progression and is associated with poor prognosis in pancreatic cancer

N Gupta, JE Park, W Tse, JK Low, OL Kon, N McCarthy… - Oncotarget, 2019 - oncotarget.com
ERO1α promotes hypoxic tumor progression and is associated with poor prognosis in pancreatic
cancer | Oncotarget Online ISSN: 1949-2553 Search: Oncotarget Home Editorial Board …

ERO1α promotes hypoxic tumor progression and is associated with poor prognosis in pancreatic cancer

N Gupta, JE Park, W Tse, JK Low, OL Kon… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Pancreatic cancer is a leading cause of mortality worldwide due to the difficulty of detecting
early-stage disease and our poor understanding of the mediators that drive progression of …